Loading...

Humana Inc.

HUMNYSE
Healthcare
Medical - Healthcare Plans
$237.98
$8.77(3.83%)

Fundamental Analysis of Humana Inc. (HUM)

Comprehensive financial metrics and ratios analysis
EPS (TTM)
$14.17
P/E Ratio
16.80
ROE
0.10%
Net Margin
0.01%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$28.73B
Shares OutstandingTotal number of shares issued
$120.69M
Book Value/ShareNet worth per share
$147.99
Revenue/ShareAnnual revenue per share
$998.81

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$14.17
Net MarginNet income as percentage of revenue
1.42%
Operating MarginOperating income as percentage of revenue
2.78%
ROEReturn on shareholders' equity
10.006%
ROAReturn on total assets
3.36%
ROCEReturn on capital employed
10.16%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$19.77
Cash/ShareCash and equivalents per share
$183.86
FCF YieldFree cash flow as percentage of market cap
8.34%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
$3.54
Dividend YieldAnnual dividend as percentage of stock price
1.50%
Financial Ratios Analysis data is not available for HUMFinancial Ratios Analysis details for HUM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for HUMSector Benchmarking details for HUM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Humana Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Humana Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Humana Inc.'s unique business strengths and challenges.

Key Financial Metrics for Humana Inc.

For Humana Inc., essential financial indicators include EPS 14.17, PE 16.80, and ROE 0.10. These key ratios reveal insights into Humana Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Humana Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Humana Inc.

Metrics like Net Margin 1.42% and ROA 3.36% shed light on how well Humana Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Humana Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Humana Inc.

Using ratios such as P/B Ratio 1.61 and PEG Ratio 0.40, investors can assess whether Humana Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Humana Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Humana Inc.

Financial health indicators, such as Debt/Equity Ratio 0.75 and Cash Flow $19.77, provide a snapshot of Humana Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Humana Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Humana Inc.

Investing in Humana Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Humana Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;